vimarsana.com

Latest Breaking News On - A biosimilar trastuzumabthursday - Page 1 : vimarsana.com

Pharmac Seeks Feedback On Widening Access And Transitioning To A Biosimilar Trastuzumab

Te Pātaka Whaioranga – Pharmac is considering awarding Principal Supply to a biosimilar brand of trastuzumab (branded as Herzuma), and widening access to include those with stomach (gastric) cancer, from 1 December 2023. Consultation on the proposal .

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.